Syra Health Corp. (NASDAQ:SYRA) Q4 2024 Earnings Call March 11, 2025 9:00 AM ET
Company Participants
Brett Maas – Investor Relations
Deepika Vuppalanchi – Chair and Chief Executive Officer
Priya Prasad – Chief Financial Officer
Brett Maas
Good morning, everyone, and thank you for joining us for Syra Health’s Fourth Quarter and Full Year 2024 Financial Results Conference Call. My name is Brett Maas of Hayden IR, and I direct Investor Relations for Syra Health.
Joining us on today’s call is Dr. Deepika Vuppalanchi, Chair and CEO of Syra Health; and Priya Prasad, Syra Health’s Chief Financial Officer. At the conclusion of today’s prepared remarks, management will answer questions that are sent to us by investors and other questions we think are relevant to investors as well.
Today’s event is being recorded and will be available for replay through the webcast information provided in the press release. I’d like to also call your attention to the customary safe harbor disclosure regarding forward-looking information. The conference call today will contain certain forward-looking statements, including statements regarding the goals, strategies, beliefs, expectations and future potential operating results of Syra Health. Although management believes these statements are reasonable based on estimates, assumptions and projections as of today, these statements are not guarantees of future performance. Time-sensitive information may no longer be accurate at the time of any telephonic or webcast replay. Actual results may differ materially as a result of risks and uncertainties and other factors, including, but not limited to, the factors set forth in the company’s financial filings with the SEC. Syra undertakes no obligations to update or revise any of these forward-looking statements.
With that said, I’d like to turn the event over to Dr. Deepika Vuppalanchi, Chair and Chief Executive Officer of Syra Health. Deepika, please go ahead.
Deepika
